The abstract is read at the publisher; the summary is JClub's.
Platelets are protective in early metabolic dysfunction-associated steatotic liver disease in nutritional preclinical murine models, enhancing liver sinusoidal endothelial fenestration via releasate.
- Why it matters: Platelets’ role in initiating and early progressing MASLD remains unclear, despite links between antiplatelet therapies and metabolic liver dysfunction.
- What they did: The study used nutritional murine MASLD models with genetic or pharmacologic manipulation of platelet count and activation, then tested platelet releasate effects on endothelial activation and fenestration.
- The result: Platelets accumulated in liver sinusoidal microvessels under steatosis and metabolic dysfunction-associated steatohepatitis, mitigating lipid accumulation and inflammation by increasing endothelial fenestration through autocrine nitric oxide-dependent signaling.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.